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i. Summary 
Phosphorylation of the serine residues in estrogen receptor (ER)  is important in transcriptional 
activation.  Hence, methods to detect such post-translational modification events are valuable.  
We describe, in detail, the analysis of the phosphorylated ER by electrophoretic separation of 
proteins and subsequent immuno-blotting techniques.  In particular, phosphorylation of the ER 
is one possible outcome of activation of the putative membrane estrogen receptor (mER), 
GPR30.   Hence, phosphorylation represents a crosstalk event between GPR30 and ER and 
may be important in estrogen-regulated physiology. 
 
ii. Keywords: phosphorylation, serine, nuclear receptor, antibody, tissue, lysate, cell 
line, GPR30, ERα 
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1.  Introduction 
Steroid hormones bind to nuclear receptors, which then act as ligand-dependent transcription 
factors, typically termed as a slow, genomic mode of action (1,2).  However, steroid hormone 
ligands can also modify nuclear receptors rapidly (3) though the consequences of such 
modification are often unclear (4-6). For example, estrogen, or the natural ligand, 17-estradiol 
(E2), can induce phosphorylation of the estrogen receptor (ER) (7,8) or reduce palmitoylation 
of ER in CHO cells (9).  The majority of phosphorylation sites on ER are on the serines in the 
N-terminal AF-1 region; mutation of this region leads to a loss in phosphorylation of ER (10).  
Two such serine residues are serine at 118 (S118), thought to be phosphorylated by ERK (11,12) 
or cdk7 and at serine 167 (S167), thought to be phosphorylated by Rsk (13) or Akt (14).  
Phosphorylation at serine S118 directs coactivator recruitment and increases gene transcription 
(15).  Phosphorylation at this site has been implicated in endocrine therapy to breast cancer 
(16,17). 
Most of the previous work has focused on the E2-mediated phosphorylation of ER, which is 
presumed to occur subsequent to the binding of the ligand to the ER (11,18).  Alternatively, 
ER could be phosphorylated in a ligand-independent manner by growth factors (19-21).  We 
have shown previously that the phosphorylation of the ER at serine 118 occurs rapidly within 
10 minutes on the administration of 10-9M E2 in the SK-N-BE(2)C neuroblastoma cell line (22).  
In addition, we have also shown that a membrane-limited conjugate, E2-BSA (10-8M), can 
rapidly increase phosphorylation of the ER at S118 in this cell line within 20 minutes of 
administration, suggesting that a) plasma membrane-initiated signaling is sufficient to 
phosphorylate the ER, and b) that the ER can be phosphorylated in a ligand-independent 
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manner in a neural cell line (22).  Such membrane-initiated actions by E2 could occur via a 
putative membrane ER, the GPR30 (23,24), which is a former orphan G-protein coupled 
receptor, localized widely in the rodent central nervous system (25). The actions of GPR30 can 
be studied with a selective agonist, G-1 (26), in tandem with the selective antagonists, G-15 (27) 
or G-36 (28), that do not bind the full-length ER.  Our study has shown that a single injection 
of G-1 (~10g/kg body weight) administered subcutaneously to gonadectomized male mice can 
induce the phosphorylation of the ER at S118 in the ventral hippocampus within 30 minutes 
(29).  A number of investigators have used polyacrylamide gel electrophoresis and subsequent 
transfer onto membranes for detection of phosphorylated ER, followed by detection of total 
ER (30-32).  However, though detection of ER at S118 is fairly routine (33), it has been fairly 
difficult to detect total full-length (66 kd) ER in the rodent brain due to the quality of the 
antibodies (34).  We present here a protocol for detection of phospho-ER from cell lines or 
from brain tissue that utilizes western blotting. 
 
2. Materials 
2.1 Components for Creating Lysates 
1. 5X RIPA buffer (Radioimmunoprecipitation assay buffer: 50 mM Tris-HCl, 150 mM 
NaCl, 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS, pH 7.4 ± 0.2). 
2. Protease Inhibitor Cocktail (Sigma Chemical Co). 
3. Phosphatase Inhibitor Cocktail 2 (Sigma Chemical Co). 
4. Phosphatase Inhibitor Cocktail 3 (Sigma Chemical Co). 
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5. Complete Lysis Buffer: (see Note 1) Combine 1mL of 5X RIPA Buffer, 50µL Protease 
Inhibitor Cocktail, 50µL Phosphatase Inhibitor Cocktail 2, and 50µL Phosphatase 
Inhibitor Cocktail 3 with enough double-distilled water (ddH2O) to bring the final volume 
to 5mL.  Store at 4°C for up to one week. 
6. Phosphate-Buffered Saline (see Note 2). 
7. Cell Scrapers for making lysates from cell cultures (see Note 3). 
8. Kimble-Chase KontesTM Pellet PestleTM for making lysates from tissue (see Note 4). 
9. Laemmli’s SDS-Sample Loading Buffer (4X, reducing) (Boston BioProducts):  375 mM 
Tris-HCl, 9% SDS, 50% glycerol, 9% β-mercaptoethanol and 0.3% bromophenol blue, 
pH 6.8.  
2.2 SDS Polyacrylamide Gel Components 
1. Resolving gel buffer: 1.5M Tris-HCl, pH 8.8.  Weigh out 18.17g of Tris Base and place 
in a beaker.  Add 80mL of ddH2O and mix.  Place buffer into refrigerator until it reaches 
4°C.  Adjust using HCl (see Note 5) until pH is 8.8 while the buffer is 4°C.  Bring 
volume to 100mL using ddH2O.  Store at 4°C. 
2. Stacking gel buffer: 0.5M Tris-HCl, pH 6.8. Weigh out 6.06g of Tris Base and place in a 
beaker.  Add 80mL of ddH2O and mix.  Place buffer into refrigerator until it reaches 4°C.  
Adjust using HCl until pH is 6.8 while the buffer is 4°C.  Bring volume to 100mL using 
ddH2O.  Store at 4°C. 
3. 30% Acrylamide/Bis solution (29:1). 
4. 10% SDS: Weigh out 10g of sodium dodecyl sulfate and place in a beaker.  Add 80mL of 
ddH2O and mix.  Adjust volume to 100mL with ddH2O.  Store in a closed container at 
room temperature (see Note 6). 
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5. 10% APS: Weigh out 10g of ammonium persulfate and put into a beaker.  Add 80mL of 
ddH2O and mix.  Adjust volume to 100mL with ddH2O.  Aliquot and store at -20°C.  
Only use freshly thawed aliquots and replace all aliquots after 6 months of storage. 
6. N,N,N’,N’-Tetramethylethylenediamine. 
2.3 Immunoblotting Components 
1. Immobilon-P PVDF Membrane, 0.45µm (see Note 7) (EMD Millipore). 
2. Running Buffer: To make 10X Running Buffer stock, weigh out 288g glycine, 60g Tris 
base, and 20g sodium dodecyl sulfate. Add to a flask containing 1.5L ddH2O and mix.  
When all components are dissolved, bring volume up to 2L with ddH2O.  Store 10X 
Running Buffer in a closed container at room temperature.   
3. To make 1X Running Buffer, add 100mL of 10X Running Buffer stock to 900mL of 
ddH2O.  1X Running Buffer may be filtered after use and reused up to 4 times and stored 
at room temperature. 
4. Transfer Buffer: To make 10X Transfer Buffer stock, weigh out 288g glycine and 60g 
Tris base. Add to a flask containing 1.5L ddH2O and mix.  When all components are 
dissolved, bring volume up to 2L with ddH2O.  Store 10X Transfer Buffer in a closed 
container at room temperature.   
5. To make 1X Transfer Buffer, combine 100mL of 10X Transfer Buffer stock with 200mL 
of methanol and 700mL of ddH2O. Store and use 1X Transfer Buffer at 4°C. 
6. TTBS (Tween-Tris buffered saline): To make 5x TBS stock, weigh out 87.7g of NaCl 
and 12.1g of Tris Base.  Mix with 1.5L ddH2O.  Adjust pH to 7.4-7.5 with HCl.  Bring 
volume to 2L with ddH2O.  Store at room temperature.   
7. To make 1X TTBS, combine 800mL ddH2O, 200mL of 5X TBS, and 1mL Tween-20.   
 7 
 
8. Blocking Solution: Weigh 5g of bovine serum albumin and mix into 90mL of 1X TTBS.  
Adjust volume to 100mL.  Store at 4°C when not in use.  Do not keep for more than 3 
days. 
9. Mini PROTEAN 3 or Tetra Running and Blotting Modules (Bio-Rad). 
10. Plastic Containers (see Note 8). 
11. Gel Blot Paper: 15x20cm sheets can be quartered to create 4 perfectly sized piece of blot 
paper. 
12. Pre-stained Protein Standards/Ladder. 
13. 1.0mm glass spacer plates, short plates, and casting module (Bio-Rad). 
14. Water-saturated isobutanol. 
2.4 Antibodies and Stripping Buffer 
1. Rabbit anti-phospho-ERα (Ser 118) antibody (SC-12915-R, Santa Cruz Biotechnology). 
2. Rabbit anti-phospho-ERα (Ser 167) antibody (sc-101676, Santa Cruz Biotechnology). 
3. Rabbit anti-ERα antibody (sc-7207, Santa Cruz Biotechnology). 
4. Goat anti-Rabbit IgG, HRP-linked antibody (see Note 9) (7074S, Cell Signaling 
Technologies). 
5. Harsh Stripping Buffer as described by Abcam.  To make 100 mL, use 20 mL of 10% 
SDS, 12.5 mL of 0.5M Tris-HCL, pH 6.8, 67.5 mL ultrapure water.  Add 0.8 mL -
mercaptoethanol in the hood.  
(http://www.abcam.com/ps/pdf/protocols/stripping%20for%20reprobing.pdf). 
2.4 Cell and Animal Treatments 
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1. Vehicle (sesame oil), E2 (200 g/mL or 10 g/50 L), G-1 (agonist of GPR30, 6 g/mL or 0.3 
g/50 L), G-15 (antagonist of GPR30, 30 g/mL or 1.5 g/50 L).  Dissolve E2, G-1, and G-
15 slowly in sesame oil at 55° for 24 h.  Store in aliquots at -20°C and remove aliquots for use; 
avoid frequent freeze-thaw cycles. 
 
3. Methods 
3.1 Tissue Procurement 
1. Gonadectomize adult mice (male or female) (~27-30 grams).  Allow 1 week for the mice 
to recover from the surgery and to ensure that gonadal hormones have cleared the 
circulation.  Make sure that all animal protocols conform to ethical procedures and are  
2. Inject gonadectomized mice with 50 L of vehicle, E2 (300 μg/kg), G-1 (10 μg/kg) 
subcutaneously.  (It may be necessary to perform dose-response analyses with selected 
agents to determine the most appropriate treatment.)  To determine whether the effect of 
G-1 or of E2 is specific, pre-treat the animals with a 5-fold molar excess of the GPR30 
antagonist, G-15, (250 μg/kg) 30 min before the administration of either E2 or G-1. 
3. Euthanize the animals 30 min after injection. 
4. Quickly remove the brain. 
5. Wash the brain in cold 1x PBS. 
6. Dissect the brain region of interest (e.g., ventral hippocampus) using a brain block.   
Alternatively, samples can be obtained from cultured primary hypothalamic neonatal 
male mouse cells or from neural cell lines. We have used final concentrations of 10-9M 
E2 and 10-8M G-1 in cell culture.  In order to block the effect of G-1, we have used both 
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10 and 100 fold excess of the antagonist;  i.e., 10-7 or 10-6M G-15. In all cases, the drugs 
or hormones are dissolved in DMSO and the concentration of DMSO added to wells in 
0.1% or less of the volume of the media present in the well containing the cells.    
3.2 Making the Lysate 
1. Follow instructions to make complete lysis buffer.  Make sure lysis buffer is ready at 4°C 
or on ice prior to use. 
2. To prepare lysate from cell culture: 
a. Remove media from cells and rinse two times with 0.5-1mL of ice-cold PBS. 
b. After removing the last rinse, add 50-100µL of complete lysis buffer to cells (see 
Note 10). 
c. Allow complete lysis buffer to sit on cells for 1-3 min. 
d. Using a pipette tip or a cell scraper, disrupt the cells and scrape them from the 
bottom of the dish.  Limit the number of bubbles generated. 
e. Pipette out buffer and cell mixture and transfer to a microcentrifuge tube. 
f. Spin tubes with cells for 10 min at 13,000-16,000xg in a refrigerated centrifuge 
set to 4°C. 
g. Remove the supernatant and transfer to a new microcentrifuge tube.   
h. Store lysate at -20°C for up to a week or at -80°C for long-term storage. 
3. To prepare lysate from brain tissue: 
a. Dissect out the brain region of interest. 
b. Place tissue into a microcentrifuge tube containing 50-200µL of complete lysis 
buffer (see Note 11). 
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c. Homogenize the tissue manually using a hand-held pestle.  Alternatively, a 
motorized pestle or tissue sonicator can be used.  These methods will provide a 
higher protein yield. 
d. When the tissue is dissociated, centrifuge the microcentrifuge tubes for 30 min at 
13,000-16,000xg in a refrigerated centrifuge set to 4°C. 
e. Pipette out the supernatant and transfer to a new microcentrifuge tube. 
f. Store lysate at -20°C for up to a week or at -80°C for long-term storage. 
3.3 Making Two Gels 
1. Place short plates and 1.0mm spacer plates into casting module.  Secure with clip. 
2. Temporarily place the 10-well plastic comb in place between the plates.  Using a wax 
pencil or marker, draw a small line on the short glass plates where the end of the teeth 
will be for the well comb.  This mark serves as the fill level for the separating gel.  
Remove the comb. 
3. To make 10% resolving gel (see Note 12), combine 5mL 1.5M Tris-HCl (pH 8.8), 6.6mL 
30% acrylamide (29:1), 200µL 10% SDS, and 8.2mL ddH2O in a 50mL conical tube. De-
gas with suction for 15 min (see Notes 13 and 14). 
4. Add 100µL 10% APS and 10µL TEMED to initiate polymerization of the gel.  Make sure 
to use a fresh aliquot of 10% APS each day. Gently rock to mix. 
5. Fill the plates with the separating gel up to the line drawn earlier. 
6. Pour or pipet enough water saturated isobutanol onto the separating gel to make a 
complete layer across the gel. 
7. Allow the gel to polymerize for 30-45 min.  If the isobutanol is on the gel any longer than 
45 min it starts drying out the gel. 
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8. During the last 15 min of the polymerization of the separating gel, begin making the 
stacking gel.  Combine 1.25mL 0.5M Tris-HCl (pH 6.8), 670µL 30% acrylamide (29:1), 
50µL 10% SDS, and 3mL ddH2O in a 15mL conical tube. Degas as described above. 
9. Once the separating gel has polymerized, pour out the isobutanol from the top of the gels.  
Rinse 2 times with ddH2O (see Note 15). 
10. Immediately before use, add 25µL 10% APS and 5µl TEMED to the stacking gel.  
Gently rock to mix. 
11. Pour the stacking gel on top of the separating gel. 
12. Insert the combs into the liquid stacking gel gently in a slight left to right movement. 
Make sure there are no bubbles under the comb. 
13. Allow to polymerize for 45 min to an hour. 
14. The gel can be used immediately after it has completely polymerized.  Alternatively, it 
can be wrapped in paper towels soaked with running buffer, wrapped in plastic wrap or in 
a plastic bag, and stored at 4°C until use, up to 2 weeks. 
3.4 Gel Electrophoresis and Blotting 
For more information on preparing protein samples for electrophoresis, please see Note 
16. 
1. Place two gels, well-comb side in, into the running apparatus. If using only one gel, place 
the plastic dam on the second side. 
2. Place the gel apparatus into the tank and fill it with 1X Running Buffer (see Note 17).  
3. Gently remove the combs from the wells.  To do this, you may have to shift the combs 
back and forth a little to help release the wells. 
4. Wash out the wells by flushing each well with running buffer a few times using a pipette.  
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5. Heat protein samples at 95°C for 8 min. After boiling, quickly centrifuge sample tubes to 
ensure that all liquid has returned to the bottom of the tube. 
6. Load 10µL of protein standards/ladder (see Note 18). 
7. Load protein samples into respective wells.   
8. In any remaining unfilled wells, add a proportionate amount of loading dye. 
9. Place the lid on the apparatus making sure to match red to red connectors and black to 
black connectors. 
10. Run the gel at 120V until there is enough separation between the ladder bands to properly 
see your band of interest. 
11. When the gel is approximately halfway through the run (the dye front is halfway down 
the gel), cut as many pieces of PVDF membrane as needed to the size of the gel (see 
Note 19).  
12. Soak the membranes in methanol for one min. Rinse off with ddH2O. Place in 1X 
Transfer Buffer for at least 15 min prior to use (see Note 20). 
13. Place the sponges and blot paper (2 each per gel) in a box of 1X Transfer Buffer to allow 
them to soak for at least 15 min prior to use. Make sure remaining 1X Transfer Buffer 
stays in the refrigerator until use. 
14. After the electrophoresis run has completed, remove the gel apparatus and the glass 
plates.  Carefully separate the short plate from the spacer plate using a plastic tool.   
15. Remove the stacking gel from the running gel with a piece of plastic and scrape the 
stacking gel away.  
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16. Gently remove the gel from the glass plates keeping track of the top of the gel. Place the 
gel in a small box filled with ddH2O to rinse off excess SDS.  Swish briefly, remove 
water, and replace with 1X Transfer Buffer.   
17. Remove running buffer and rinse out the tank with ddH2O to remove excess SDS. 
18. Insert the blotting module and an ice pack into the tank and place it on a stir plate.  Insert 
a small magnetic stir bar and a small amount of 1X Transfer Buffer.  Make sure the stir 
bar can spin freely before continuing any further. 
19. Assemble the transfer sandwich on the open transfer cassette with the black side down.  
Start building the sandwich on the black side.  Place down one sponge and top it with one 
piece of blot paper.  Gently transfer the gel to the top of the filter paper keeping track of 
the top of the gel. It is preferable to place the protein marker/ladder at the top, with the 
top portion where the wells were facing the inner side of the cassette. Make sure to pour 
liberal amounts of 1X Transfer Buffer over and between every layer to ensure that the 
sandwich remains moist and air bubbles do not form.  It is recommended to do this step 
over a secondary plastic container to catch excess buffer overflow. 
20. Carefully place a piece of presoaked PVDF membrane over the gel, ensuring that no 
bubbles form between the membrane and the gel.  
21. Top with another piece of blot paper and another sponge. 
22. Close the sandwich cassette and insert it with the black side of the cassette facing the 
black side of the transfer apparatus. 
23. Fill the tank with 1X Transfer Buffer.  Replace the lid. Transfer at a 300mA for 60-90 
min. 
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24. Do not allow the transfer to get too warm.  Check the transfer every 15 min to ensure that 
it does not overheat.  The entire transfer apparatus can be placed into a bucket of ice on 
the stir plate to keep the temperature down longer to allow for more complete transfers 
(see Note 21). 
3.5 Blocking and Antibody Incubation 
1. After the transfer is complete, disassemble the sandwiches and remove the membrane.  
Place the membrane into a small plastic box containing 7-10mL of 5% BSA/TTBS (see 
Note 22). 
2. Place the box on orbital shaker for 1 h (see Note 23). 
3. When the blocking step is near completion, begin making the primary antibody mixtures 
to image phospho-ERα on the membrane.  5% BSA /TTBS is used to make all primary 
antibody mixtures.  Allow 7-10mL per blot.  (If using systems like the LiCOR Odyssey 
system with primaries of different species, co-incubation of primary antibodies of 
different species is possible.) 
The antibody dilutions, incubation times, and incubation temperatures are:  
a. Rabbit anti-phospho-ERα (Ser 118): Dilute 1:4,000. Incubate for 1h at room 
temperature on orbital shaker. 
b. Rabbit anti-phospho-ERα (Ser 167): Dilute 1:750. Incubate overnight at 4°C on 
orbital shaker. 
4. Following incubation in primary antibody, rinse the blot in TTBS four times, 10 min per 
wash on an orbital shaker.  The box should be approximately one-third full with TTBS. 
5. Prepare the secondary antibody cocktail using 5% BSA/TTBS.  Dilute Goat anti-Rabbit 
HRP conjugated secondary antibody to 1:50,000 (see Note 9). 
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6. Incubate blots in secondary antibody cocktail for one h at room temperature on an orbital 
shaker. 
7. Following incubation in secondary antibody, rinse the blot in TTBS six times, 10 min per 
wash on orbital shaker.  Box should be approximately one-third full with TTBS. 
8. Visualize the blot as desired (see Note 24). 
9. Strip the anti-phospho-ERα antibodies from the membrane using protocol and buffer 
from Abcam (see Note 25) in preparation for imaging nonphosphorylated ERα.   
10. Following the required rinses in water, wash the blot with TTBS four times, 10 min per 
wash on orbital shaker. 
11. Re-block membrane using 5% BSA in TTBS (see Note 26). 
12. When the blocking step is near completion, begin making the ERα primary antibody 
mixture using 5% BSA in TTBS.   
a. If the protein source was cell culture lysates: Dilute ERα antibody 1:4,000. Incubate 
the membrane in this primary antibody overnight at 4°C on an orbital shaker. 
b. If the protein source was tissue lysates: Dilute ERα antibody 1:1,000. Incubate the 
membrane in this primary antibody overnight at 4°C on orbital shaker. 
13. Rinse in TTBS four times, 10 min per wash on orbital shaker. 
14. Prepare the secondary antibody mixture using 5% BSA/TTBS.  Dilute Goat anti-Rabbit 
HRP conjugated secondary antibody to 1:50,000 when the protein source is cell culture 
lysates or 1:20,000 when the protein source is tissue lysates. 
15. Incubate blots in secondary antibody cocktail for one h at room temperature on orbital 
shaker. 
16. Rinse with TTBS four times, 10 min per wash on orbital shaker. 
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17. Develop blot as desired (see Note 24 and Note 27). 
18. The expected results may vary depending on the dose.  However, we have seen an 
increase in phosphorylated ER at S118 in ventral hippocampal tissues treated with the 
GPR30 agonist, G-1, as compared to the vehicle treated tissue.  In addition, we expect 
that this increase is blocked in tissues treated with the GPR30 antagonist, G-15. Though 
the phospho-S118 ER antibody detects a strong band of 66 kd, the antibodies that detect 
total ER often detect bands of other sizes such as 52 kd, 46 kd, 60 kd and sometimes 
higher molecular weight bands of about 72 kd in the mouse brain.  The 66kd band 
detected by this antibody in tissue is often lower in intensity to the other bands.  This is in 
contrast to the scenario in uterine tissue from the rat or mouse, where the 66 kd band 
detected by the total ER antibody is the predominant band. 
4. Notes 
1. Ultrapure water (~18MΏ) should be used whenever ddH2O is required. 
2. PBS made in the lab from a standard recipe works just as well as premade PBS for these 
purposes. 
3. Whether or not cell scrapers are useful will have to be determined by the experimenter 
and the method in which the cells are cultured.  Small areas of cells (e.g., 24-well plates) 
are easily scraped using a 200µL pipette tip instead of a scraper. 
4. These pestles can be used to mechanically dissociate the tissue.  Other methods of tissue 
homogenization can be used.   
5. A 6N HCl solution can be used for adjusting pH. 
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6. Stirring the 10% SDS solution can create a large amount of bubbles.  It is recommended 
to stir this slowly or wait for the bubbles to settle down before adjusting with ddH2O to 
final volume. 
7. PVDF membranes work well for the protocol described.  However, the membrane should 
be chosen based on methods of developing the final product.  For instance, a low 
fluorescence membrane is recommended when using infrared secondary antibodies. 
8. Plastic containers should be as close to the size of the blot as possible to reduce waste of 
reagents.  Our lab has found that the boxes used to sell push pins are of the perfect size 
for blots made using a Mini-PROTEAN 3 or Tetra system.  
9. The method described here is based on using HRP substrates and film to develop the final 
product.  However, there are alternative methods of developing a Western blot and the 
secondary antibody chosen should match the developing method. 
10. The exact amount of complete lysis buffer used is highly dependent on cell density and 
the surface area of the culture dish.  It is recommended to run a few trials to find the 
optimal amount of lysis buffer for an experiment. 
11. Similar to making cell culture lysates, the amount of complete lysis buffer needed varies 
greatly on brain region and sample size.  It is recommended to run test trials to determine 
the optimal amount of lysis buffer for the sample.  Particularly large samples of tissue 
may be subdivided into multiple tubes to facilitate homogenization. 
12. Both phosphorylated versions of ERα described in this protocol work well with either 
7.5% or 10% resolving gels.  If another protein needs to be probed on the same blots as 
phospho-ERα, a different percentage gel can be used to optimize the other protein 
without causing problems in phospho-ERα detection. 
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13. Degassing a gel improves the quality of results, but is not necessary if no methods of 
degassing are available. 
14. To make a 7.5% resolving gel, combine 3mL 1.5M Tris-HCl (pH 8.8), 3mL 30% 
acrylamide (29:1), 120µL 10% SDS, and 5.75mL ddH2O.  Add 120µL 10% APS and 
12µL TEMED to initiate polymerization of the gel. 
15. Take care to remove as much of the isobutanol as possible.   
16. The volume of each component that is used depends on the quantity (in μg) of protein 
you want to load and the total volume of the mixture you want to load.  The amount of 
protein loaded is determined through optimization work.  We have found that 20µg is 
sufficient for detection of most proteins we use but this can be adjusted as needed.   As 
far as total volume of the mixture, you can load an absolute maximum volume of 30µL 
into a 10 well gel.  However, it is easier and more desirable to load smaller volumes to 
minimize spillover between lanes.  The ideal loading volume is 20µL for 10 well gels.  
The amount of Laemmli Sample loading buffer (SLB) used is 1/3 of the total volume of 
the mixture and the amount of RIPA used is the volume required to dilute each sample to 
the same total volume. 
17. The fill line will be labeled on the tank if using a Mini-PROTEAN Tetra system or to the 
top of the gels if using a Mini-PROTEAN 3 system. 
18. Specialized loading tips are recommended.  These tips facilitate complete transfer of 
sample to wells.  However, 200µL tips are an acceptable substitute. 
19. It is recommended to have a cardboard template cut for this purpose. 
20. Old pipette tip boxes make excellent containers for this part of the protocol. 
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21. Constant voltage can be used instead of constant amperage for the transfer.  This choice 
is dependent on time and other variables.  The selection of either constant voltage or 
constant amperage should not alter the end result when working with the described 
antibodies. 
22. Coomassie solution can be used to counterstain the gels to check for transfer of protein or 
quality of remaining protein.   
23. It is not recommended to block the blots for an extended period of time.  Extended 
blocking can enhance background or lead to protein transfer from the blots.  Additionally, 
the use of 5% BSA/TTBS may be inappropriate for different developing methods and 
cause exogenous background (e.g., infrared detection methods). 
24. We recommend using SuperSignal West Femto Chemiluminescent Substrate and 
developing the blot with film. 
25. The harsh stripping protocol by Abcam is very effective. Perform this procedure in a 
fume hood and make sure to rinse the blot adequately with TBST afterwards since traces 
of -mercaptoethanol may damage the antibody. 
26. We recommend checking the effectiveness of the antibody strip by reincubating the blot 
in secondary antibody and visualizing.  If old primary antibodies were stripped from the 
membrane, no signal should be detected.  We have not seen any loss of protein from the 
membrane using this protocol. 
27. A control protein should be probed to allow for normalization of protein bands to control 
for any variations in loading. 
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